Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Heartseed Inc. logo — Clinical-stage biotech company developing iPSC-derived highl...

Heartseed Inc.

Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure

Founded 2015 Japan Japan 21 employees IPO Total: $184.62M Biotechnology, Care Economy +3

General Information

Company Name Heartseed Inc.
Founded Year 2015
Location Japan Japan
Employees 21
Industries Biotechnology, Care Economy, Health Care +2
Funding Stage IPO
Business Model B2B, B2D, B2B2C
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Heartseed Inc.. To contact Heartseed Inc., visit heartseed.jp.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Heartseed Inc. compare?

A PDF of Heartseed Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Heartseed Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Heartseed Inc.

Heartseed Inc. is a clinical-stage biotech company known for its expertise in developing iPSC-derived highly purified ventricular cardiomyocytes, a technology poised to revolutionize the treatment of heart failure. Founded in 2015 and headquartered in Japan, the company operates at the intersection of multiple industries including Biotechnology, Health Care, and Pharmaceuticals.

Utilizing cutting-edge stem cell technology, Heartseed Inc. crafts cardiomyocyte spheroids, which are tiny clusters of heart cells transplanted surgically to enhance heart functionality. This groundbreaking approach positions the company as a leader in the care economy and wellness beauty sectors.

The company is preparing for its next stage of growth, with plans for an IPO investment on 01 July 2024. The anticipated public offering reflects confidence in Heartseed's innovative technologies and their potential to impact the global health care market significantly.

Business keywords: iPSC-derived ventricular cardiomyocytes, heart failure treatment, cardiomyocyte spheroids, myocardial regenerative medicine, cell therapy, biotech innovation, stem cell technology, cardiovascular therapy, heart cell transplantation, clinical-stage biotech, regenerative medicine, cardiac cell therapy, biotherapeutics, cardiovascular regeneration

Services & Products

Cardiac Regenerative Medicine Development
Clinical Research and Trials
Biotechnology and Stem Cell Product Development

Target Customers

Patients with Heart Failure Medical Practitioners in Cardiac Healthcare Healthcare Institutions Researchers in Cardiovascular Medicine

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
IPO Undisclosed -
01 Jul 2024
Series D $14.41M 10
SMBC Venture Capital Japan Co-Invest Keio Innovation Initiative
SMBC Venture Capital, Japan Co-Invest +8
01 May 2023
Series C $37.00M 9
Nissay Capital SMBC Venture Capital Keio Innovation Initiative
Nissay Capital, SMBC Venture Capital +7
01 Jun 2021
Series B $26.00M 4
Nissay Capital SMBC Venture Capital Science
Nissay Capital, SMBC Venture Capital +2
01 Nov 2019
Series A $7.21M 3
Angel Bridge
Angel Bridge, Astellas Pharma +1
01 Jul 2018
Seed ¥100.00M 1
Angel Bridge
Angel Bridge
01 Mar 2016
Spinout Undisclosed 1
The University of Tokyo
01 Jan 2015

Heartseed Inc. Alternatives & Competitors

View All Alternatives
Heartseed Inc. vs
BlueRock Therapeutics
BlueRock Therapeutics United States

Striving to transform the treatment of disease by harnessing the power of cell therapy

Acquired
478 employees
Biopharma, Biotechnology
Heartseed Inc. vs
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. United States

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS...

Series C
128 employees
Biotechnology, Health and Wellness
Heartseed Inc. vs
Fate Therapeutics Inc.
Fate Therapeutics Inc. United States

Transforming the lives of patients with autoimmune diseases and cancer.

227 employees
Biotechnology, Health Care
Also compare with: Heartseed Inc. vs Orca Bio Orca Bio Heartseed Inc. vs Tenaya Therapeutics Tenaya Therapeutics View all alternatives

FAQ About Heartseed Inc.

Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
Heartseed Inc. was founded in 2015.
Heartseed Inc. is headquartered in Japan.
Heartseed Inc. operates in Biotechnology, Care Economy, Health Care, Pharmaceutical and Wellness Beauty. Its work centres on iPSC-derived ventricular cardiomyocytes, heart failure treatment, cardiomyocyte spheroids and myocardial regenerative medicine. Its customers include Patients with Heart Failure, Medical Practitioners in Cardiac Healthcare and Healthcare Institutions.
Heartseed Inc. has a B2B, B2D and B2B2C business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Heartseed Inc. has approximately 21 employees.
Heartseed Inc. has completed 7 funding rounds, raising a total of $184.62M. The latest funding stage is IPO.
Heartseed Inc. offers: Cardiac Regenerative Medicine Development, Clinical Research and Trials, Biotechnology and Stem Cell Product Development.
Top alternatives and competitors to Heartseed Inc. include BlueRock Therapeutics, Aspen Neuroscience, Inc., Fate Therapeutics Inc., Cardior Pharmaceuticals, Orca Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Heartseed Inc. and BlueRock Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Heartseed Inc., https://bouncewatch.com/company/heartseed-inc, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes